| 000 | 01539 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516202925.0 | ||
| 264 | 0 | _c20150422 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1365-2133 | ||
| 024 | 7 |
_a10.1111/bjd.12913 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Y Y | |
| 245 | 0 | 0 |
_aDNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis. _h[electronic resource] |
| 260 |
_bThe British journal of dermatology _cJul 2014 |
||
| 300 |
_a39-47 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntimetabolites _xpharmacology |
| 650 | 0 | 4 |
_aAzacitidine _xpharmacology |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xmetabolism |
| 650 | 0 | 4 |
_aDNA Methylation _xphysiology |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aForkhead Transcription Factors _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aScleroderma, Systemic _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes, Regulatory _xdrug effects |
| 700 | 1 | _aWang, Q | |
| 700 | 1 | _aSun, X H | |
| 700 | 1 | _aLiu, R Z | |
| 700 | 1 | _aShu, Y | |
| 700 | 1 | _aKanekura, T | |
| 700 | 1 | _aHuang, J H | |
| 700 | 1 | _aLi, Y P | |
| 700 | 1 | _aWang, J C | |
| 700 | 1 | _aZhao, M | |
| 700 | 1 | _aLu, Q J | |
| 700 | 1 | _aXiao, R | |
| 773 | 0 |
_tThe British journal of dermatology _gvol. 171 _gno. 1 _gp. 39-47 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjd.12913 _zAvailable from publisher's website |
| 999 |
_c23651677 _d23651677 |
||